Literature DB >> 12160450

Control of spread of Methicillin Resistant Staphylococcus aureus (MRSA) in Burns Units.

James N. Muthotho1, Peter G. Waiyaki, Michael Mbalu, Anne Wairugu, Beth Mwanthi, Ben Odongo.   

Abstract

Results of four years' studies from a number of hospitals in Kenya have shown that nosocomial infections in burns units are due to Methicillin Resistant Staphylococcus aureus (MRSA). Through chromosomal DNA and plasmid DNA, the stain is highly resistant to sulphonamide ointment and other antibiotics. 90% of patients admitted in burns units get colonized or infected with MRSA. The strain prolongs the duration of patients in hospitals. The burns degenerate to second and third degree burns, thereby necessitating skin grafting. The environment has been found to be contaminated with this strain with some staff members having chronic throat infections. Minocycline was found to be effective in treating the infected staff members. Cleaning this environment with Sodium dichloroisocyanurate (precepts)/Sodium hypochlorite (JIK) reduced drastically the mechanical transmission of bacteria in the units. The duration of stay of the patient was reduced. This shows that MRSA which is spread in government and private hospitals can cheaply be controlled by the proper use of disinfectants, antiseptics, and use of effective antibiotics when necessary.

Entities:  

Year:  1995        PMID: 12160450

Source DB:  PubMed          Journal:  Afr J Health Sci        ISSN: 1022-9272


  2 in total

1.  Emergence of a community-associated methicillin-resistant Staphylococcus aureus strain with a unique resistance profile in Southwest Nigeria.

Authors:  B Ghebremedhin; M O Olugbosi; A M Raji; F Layer; R A Bakare; B König; W König
Journal:  J Clin Microbiol       Date:  2009-07-01       Impact factor: 5.948

2.  Carriage of Staphylococcus aureus in Thika Level 5 Hospital, Kenya: a cross-sectional study.

Authors:  Alexander M Aiken; Irene M Mutuku; Artur J Sabat; Viktoria Akkerboom; Jonah Mwangi; J Anthony G Scott; Susan C Morpeth; Alexander W Friedrich; Hajo Grundmann
Journal:  Antimicrob Resist Infect Control       Date:  2014-07-15       Impact factor: 4.887

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.